PDCD1 and glioblastoma: As shown in Figs. 7A and S3, compared with control group, IR group, PD-1 inhibitor group and IR + PD-1 inhibitor group, the addition of A2-CM-NP/siTREM2/spam1 to them significantly facilitated T cells (CD3+) infiltrated to GBM region.